Baylis Medical Technologies has announce it is assuming responsibility for the sales and distribution of the steerable and guiding sheaths currently sold direct-to-hospital by Oscor in the USA.
The addition of Oscor’s sheath portfolio will allow Baylis Medical Technologies to broaden its clinical solution offerings in radiology and vascular surgery, a company press release reads.
“This strategic partnership will allow Baylis Medical Technologies to expand our vascular footprint in the USA. It will strengthen our ability to provide current and future customers with dedicated clinical solutions that enable endovascular and other therapies,” says Kris Shah, president of Baylis Medical Technologies.
The sheath portfolio will complement the company’s existing product offerings, including the PowerWire radiofrequency guidewire.
Oscor and Baylis Medical Technologies have begun the transfer of the business and, according to Baylis, will continue working closely together to ensure the transition has minimal impact on customers.